The management of daily medications is a critical part of the control of cases and the prevention of relapses for people with mental health problems. The following are some of the key knowledge of the daily medicine management of patients in the brain.
I. Occupancy of medications in accordance with medical instructions
The patient in the head must use the medication strictly in accordance with the doctor ‘ s orders and cannot reduce the quantity, stop or change it. Doctors develop individualized medication programmes based on the patient’s specific condition, such as the type of brain infarction or brain haemorrhage, the extent of the disease, the overall state of the body and other complications. For example, some patients need to take long-term anti-sculpture drugs, such as aspirin or chlorpelle, to prevent re-emergence. Self-reducing or detoxification can lead to a re-emergence of a hemorrhagic embolism, leading to a re-emergence of a second brain, with an unforeseeable consequence.
Understanding the role and care of commonly used drugs
1. Anti-sculpable tablets: As mentioned earlier, aspirin and chlorpluent gray can inhibit the accumulation of slabs, reduce blood condensation and reduce the risk of leaching. However, the use of aspirin may have side effects such as gastrointestinal discomfort, haemorrhage, etc., in cases of black shit, haemorrhage, etc., and should be promptly notified to the doctor. Chlorocylene is less responsive than the gastrointestinal tract, but may be more expensive.
Tatin-type drugs: These are mainly used to reduce blood resins and to stabilize the sclerosis of porridge samples. The most common are Atophate, Rishuptadine and others. During the use of histinoids, patients are required to periodically review indicators such as liver function, myoacidase, etc., as there may be adverse effects such as liver function impairment, muscle pain, etc. In case of muscular pain, infirmity, etc., medical examinations should be conducted in a timely manner.
3. Pressure-relief medicines: hypertension is an important risk factor in the brain, and many of them require long periods of time to control blood pressure. Common decompressants are nitro-benzene, aminochloride, saltan, Elbezatan, etc. Patients are required to measure blood pressure on time, observe blood pressure fluctuations and record them so that doctors can adjust the dosage. The depressure cannot be too fast or too low, otherwise it may lead to a lack of brain infusion, resulting in dizziness, powerlessness or even brain infarction.
4. Sugar medicine: Controlling blood sugar is essential for patients with diabetes. There is a wide variety of sugar medicines, including platinum, gelazit, insulin, etc. Patients are required to eat strictly in accordance with the requirements of the diabetes diet, to monitor blood sugar on a regular basis, and to adjust the dose of sugar reduction or insulin use to the blood sugar values. Care should also be taken to prevent low blood sugar reactions, to carry sweets with them and to alleviate their consumption in a timely manner in the event of low blood sugar symptoms such as panic, hand shaking, sweating and hunger.
III. Storage and custody of drugs
It is also important that drugs be properly preserved. Most drugs should be stored in cold, dry and light-shield areas to avoid high temperatures, humidity and sunlight. Some drugs require cold storage, such as certain biological agents, insulin, etc., and are kept at the temperature strictly required by the instructions. Drugs should be placed in places where children are not easily accessible to prevent misadventure.
Avoiding drug interaction
Patients in the brain may suffer from multiple diseases at the same time and require multi-drugs. Attention should be paid to the existence of interaction between drugs in the course of their use. For example, the combination of aspirin with some anticondensants may increase the risk of haemorrhage; the incidence of adverse effects of other antibiotics may increase when the combination of histin and some antibiotics. During visits, the patient must inform the doctor of all the drugs he is taking, including prescription drugs, non-prescription drugs, health care, etc., so that the doctor can assess them in a comprehensive manner and adjust the programme.
V. Periodic review and adjustment of medications
Patients cannot assume that they have taken drugs, and regular review is essential. By reviewing indicators such as blood protocol, coagulation function, liver and kidney function, blood resin, blood sugar, blood pressure, etc., doctors are able to understand the efficacy and adverse effects of the drug and adjust the dose or replace the drug in a timely manner, based on the results of the examination. In general, review may be more frequent at the beginning of the medication, e.g., once every 1-2 weeks, with an appropriate lengthening of the interval for review once the condition has stabilized, e.g. once every 1-3 months.
In short, the day-to-day management of medicines for patients in the brain is a complex and critical task. Patients and their families need to be fully aware of the importance of the correct use of drugs and to work actively with doctors to manage them so as to better control the situation, improve the quality of life and reduce the risk of relapse into the brain.
